Breton additionally mentioned he anticipated that the prices of the EU’s current order for more doses of Pfizer-BioNTech vaccines can be increased than the sooner variations.
The Commission final month launched authorized motion towards AstraZeneca for not respecting its contract for the availability of COVID-19 vaccines and for not having a “reliable” plan to make sure well timed deliveries.
“We did not renew the order after June. We’ll see what happens,” mentioned Breton, including that it was “a very good vaccine”.
Concerns has risen on potential side-effects of the Anglo-Swedish COVID-19 vaccine.
Europe’s medicines regulator mentioned on Friday it’s reviewing studies of a uncommon nerve-degenerating dysfunction in individuals who acquired the photographs, a transfer that comes after it discovered the vaccine might have triggered very uncommon blood clotting circumstances.
Breton mentioned a rise in costs for second era vaccines might be justified by the additional analysis required and potential adjustments to industrial tools.
The European Union signed a brand new contract with Pfizer-Biontech to obtain 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cowl booster photographs, donations and reselling of doses, the European Commission mentioned on Friday.
“There may be a little extra cost but I will let the competent authorities unveil it in due course,” he advised France Inter radio.